345 related articles for article (PubMed ID: 6139495)
1. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
[TBL] [Abstract][Full Text] [Related]
2. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin-releasing hormone (TRH) and its analog (DN-1417): interaction with pentobarbital in oxygen consumption and cyclic AMP formation of rat cerebral cortex slices.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Life Sci; 1984 May; 34(22):2177-84. PubMed ID: 6328158
[TBL] [Abstract][Full Text] [Related]
4. A TRH analog (DN-1417): motor stimulation with rearing related to catecholaminergic mechanisms in rats.
Miyamoto M; Narumi S; Nagai Y; Saji Y; Nagawa Y
Neuropharmacology; 1984 Jan; 23(1):61-72. PubMed ID: 6425711
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin-releasing hormone (TRH) and its analog (DN-1417): interaction with pentobarbital in choline uptake and acetylcholine synthesis of rat brain slices.
Narumi S; Nagai Y; Miyamoto M; Nagawa Y
Life Sci; 1983 Apr; 32(14):1637-45. PubMed ID: 6403792
[TBL] [Abstract][Full Text] [Related]
6. [A TRH analog (DN-1417). Effects on the levels of monoamines and the metabolites in the various brain regions in rats].
Nagai Y; Narumi S; Miyamoto M; Shima T; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):209-20. PubMed ID: 3924795
[TBL] [Abstract][Full Text] [Related]
7. TRH and its novel analog (DN-1417): antipentobarbital action and involvement of cholinergic mechanisms.
Miyamoto M; Nagai Y; Narumi S; Saji Y; Nagawa Y
Pharmacol Biochem Behav; 1982 Oct; 17(4):797-806. PubMed ID: 6817348
[TBL] [Abstract][Full Text] [Related]
8. [A TRH analog (DN-1417). Blood level and brain distribution determined by radioimmunoassay after intravenous administration in rats].
Nagai Y; Narumi S; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):231-42. PubMed ID: 3924797
[TBL] [Abstract][Full Text] [Related]
9. In vitro thyrotrophin release with thyrotropin-releasing hormone and an analogue, DN-1417.
Shiota K; Yoshida K; Noguchi C; Nakayama R
Acta Endocrinol (Copenh); 1984 May; 106(1):71-8. PubMed ID: 6428117
[TBL] [Abstract][Full Text] [Related]
10. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone.
Mailman RB; Frye GD; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1979 Feb; 208(2):169-75. PubMed ID: 33261
[TBL] [Abstract][Full Text] [Related]
11. [A TRH analog (DN-1417). Antagonistic effects on reserpine-induced decreases in local cerebral glucose utilization and cerebral monoamine levels].
Nagai Y; Narumi S; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 May; 85(5):315-26. PubMed ID: 3928465
[TBL] [Abstract][Full Text] [Related]
12. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
Narumi S; Nagawa Y
Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
[TBL] [Abstract][Full Text] [Related]
13. A TRH analog (DN-1417): effects on local cerebral glucose utilization in conscious and pentobarbitalized rats determined by the autoradiographic 2-deoxy-[14C]glucose method.
Nagai Y; Narumi S; Miyamoto M; Saji Y; Nagawa Y
Jpn J Pharmacol; 1983 Jun; 33(3):635-45. PubMed ID: 6413736
[TBL] [Abstract][Full Text] [Related]
14. [TRH and its analog (DN-1417). Effects on central dopaminergic system-dependent behaviors in rats and mice].
Miyamoto M; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):129-41. PubMed ID: 3924793
[TBL] [Abstract][Full Text] [Related]
15. Intestinal absorption mechanisms of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide citrate (DN-1417) and thyrotropin-releasing hormone (TRH).
Yokohama S; Yoshioka T; Kitamori N; Shimamoto T; Kamada A
J Pharmacobiodyn; 1985 Apr; 8(4):278-85. PubMed ID: 3928869
[TBL] [Abstract][Full Text] [Related]
16. Effects of thyrotropin releasing hormone and its analogue, DN 1417, on biopterin concentration and tryptophan hydroxylation in rat raphe slices.
Sawada M; Hirata Y; Minami M; Nagatsu T
Life Sci; 1987 Dec; 41(25):2733-7. PubMed ID: 3121968
[TBL] [Abstract][Full Text] [Related]
17. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
[TBL] [Abstract][Full Text] [Related]
18. Effect of TRH analog (DN-1417) on tyrosine hydroxylase activity in mesocortical, mesolimbic and nigrostriatal dopaminergic neurons of rat brain.
Yokoo H; Nakahara T; Matsumoto T; Inanaga K; Uchimura H
Peptides; 1987; 8(1):49-53. PubMed ID: 2883633
[TBL] [Abstract][Full Text] [Related]
19. Effect of DN-1417, a thyrotropin releasing hormone analog, on dopaminergic neurons in rat brain.
Nakahara T; Matsumoto T; Hirano M; Uchimura H; Yokoo H; Nakamura K; Ishibashi K; Hirano H
Peptides; 1985; 6(6):1093-9. PubMed ID: 3938840
[TBL] [Abstract][Full Text] [Related]
20. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
